Feasibility of using <scp> <i>P16</i> </scp> methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study-Reference-Cited by-同舟云学术

Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study

Published:2022-03-29 Issue:21 Volume:11 Page:4033-4042
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Fan Zhiyuan¹^ORCID,Qin Yu¹,Zhou Jing²,Chen Ru¹,Gu Jianhua¹^ORCID,Li Minjuan¹,Zhou Jiachen³^ORCID,Li Xinqing¹,Lin Dongmei⁴,Wang Jinwu⁵,Deng Dajun²,Wei Wenqiang¹^ORCID

Affiliation:

1. Office of National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology Peking University Cancer Hospital and Institute Beijing China

3. Department of Epidemiology and Biostatistics, School of Public Health Xi'an Jiaotong University Health Science Center Xi'an China

4. Department of Pathology Peking University Cancer Hospital Beijing China

5. Department of Pathology Linzhou Cancer Hospital Linzhou China

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4718